SURMOUNT-OSA: Tirzepatide and obstructive sleep apnea The SURMOUNT-OSA trial (Malhotra et al., NEJM 2024, NEJMoa2404881, PMID 38912654) evaluated tirzepatide in adults with moderate to severe obstructive sleep apnea and obesity, in two parallel populations: subjects not receiving continuous positive airway pressure (CPAP) and subjects receiving CPAP at baseline
GLP-1 medications can be taken long-term if they continue to be effective and well-tolerated
From the ultimate hydrofacial experience and Morpheus8 radio-frequency microneedling to advanced medical-grade exfoliation tracks (TCA, Jessner, and Retinol), we meticulously condition your skin at a cellular level to reveal a flawless, radiant canvas
Key differences arise in the method of administration and personal preferences
You need preauthorization within 30 days of receiving the product, and the warehouse must receive the return within 14 days of authorization
Additionally, it offers cardiovascular benefits, such as reduced risk of heart attack and stroke, making it a valuable option for those with weight-related and diabetic conditions